In this study, treatment with osthole normalized histamine/LPS-mediated immunological dysregulation in AD in 3D skin model by significantly decreasing the secretion of IL-1β, IL-6, IL-8, TNF-α, CCL5/RANTES, CC2/MCP-1 and COX-2. Here, CCL2 is linked to Alzheimer disease.